论文部分内容阅读
目的:探讨血清肿瘤标志物与恶性肿瘤诊断的关系,为早期诊断恶性肿瘤提供辅助性依据。方法:收集经病理诊断为恶性肿瘤患者的标本进行肿瘤标志物检测并分析。结果:2015年1月~2015年11月在云南省肿瘤医院肿瘤研究所检测肿瘤标志物的1284人,其中118人检测结果正常,占总数的9.19%,1166个中至少有一项异常,占90.81%;1284人恶性肿瘤患者共检测肿瘤标志物15408项,其中异常项2425,异常率15.74%。结论:肿瘤标志物的检测对早期肿瘤的筛查、发现、诊断有一定的价值,但是检测的阳性率低,特异性较差,只能为恶性肿瘤诊断提供辅助依据,而不能作为诊断的金标准。
Objective: To explore the relationship between serum tumor markers and the diagnosis of malignant tumors and to provide ancillary evidence for the early diagnosis of malignant tumors. Methods: Specimens collected from pathologically diagnosed malignant tumors were collected and tested for tumor markers. Results: From January 2015 to November 2015, 1284 tumor markers were detected in the Oncology Institute of Yunnan Tumor Hospital. Among them, 118 showed normal results, accounting for 9.19% of the total, with at least one of 1166 abnormalities accounting for 90.81 %; A total of 15,408 tumor markers were detected in 1284 malignant tumor patients, of which 2425 were abnormal and the abnormal rate was 15.74%. Conclusion: The detection of tumor markers has certain value in the screening, diagnosis and diagnosis of early tumors. However, the positive rate of detection is low and the specificity is poor. It can only provide the auxiliary evidence for the diagnosis of malignant tumors, but not for the diagnosis standard.